63 related articles for article (PubMed ID: 11158048)
1. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature.
Andrews A; Cottrell E; Maharaj A; Ladha T; Williams J; Schilbach K; Kaisinger LR; Perry JRB; Metherell LA; McCormick PJ; Storr HL
Eur J Endocrinol; 2023 Apr; 188(4):353-365. PubMed ID: 36943306
[TBL] [Abstract][Full Text] [Related]
2. Esterase 1 is a novel transcriptional repressor of growth hormone receptor gene expression: a unique noncatalytic role for a carboxyesterase protein.
Sun J; Kumar PA; Thimmarayappa J; Saini N; Goel P; Maures T; Lu C; Menon RK
Mol Endocrinol; 2011 Aug; 25(8):1351-63. PubMed ID: 21659478
[TBL] [Abstract][Full Text] [Related]
3. The acute effects of growth hormone in adipose tissue is associated with suppression of antilipolytic signals.
Høyer KL; Høgild ML; List EO; Lee KY; Kissinger E; Sharma R; Erik Magnusson N; Puri V; Kopchick JJ; Jørgensen JOL; Jessen N
Physiol Rep; 2020 Feb; 8(3):e14373. PubMed ID: 32073221
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans.
Young JA; Hinrichs A; Bell S; Geitgey DK; Hume-Rivera D; Bounds A; Soneson M; Laron Z; Yaron-Shaminsky D; Wolf E; List EO; Kopchick JJ; Berryman DE
Pituitary; 2023 Dec; 26(6):660-674. PubMed ID: 37747600
[TBL] [Abstract][Full Text] [Related]
5. Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice.
List EO; Berryman DE; Ikeno Y; Hubbard GB; Funk K; Comisford R; Young JA; Stout MB; Tchkonia T; Masternak MM; Bartke A; Kirkland JL; Miller RA; Kopchick JJ
Aging (Albany NY); 2015 Jul; 7(7):500-12. PubMed ID: 26233957
[TBL] [Abstract][Full Text] [Related]
6. Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.
Dong X; Su L; Patti ME
Curr Diab Rep; 2022 Oct; 22(10):511-524. PubMed ID: 36001217
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone receptor gene disruption.
List EO; Duran-Ortiz S; Kulkarni P; Davis E; Mora-Criollo P; Berryman DE; Kopchick JJ
Vitam Horm; 2023; 123():109-149. PubMed ID: 37717983
[TBL] [Abstract][Full Text] [Related]
8. The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.
Dehkhoda F; Lee CMM; Medina J; Brooks AJ
Front Endocrinol (Lausanne); 2018; 9():35. PubMed ID: 29487568
[TBL] [Abstract][Full Text] [Related]
9. Giant mice reveal new roles for GH in regulating the adipose immune microenvironment.
Odle AK; Drew PD; Childs GV
Endocrinology; 2015 May; 156(5):1613-5. PubMed ID: 25886070
[No Abstract] [Full Text] [Related]
10. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.
Berryman DE; Glad CA; List EO; Johannsson G
Nat Rev Endocrinol; 2013 Jun; 9(6):346-56. PubMed ID: 23568441
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?
Giannoulis MG; Martin FC; Nair KS; Umpleby AM; Sonksen P
Endocr Rev; 2012 Jun; 33(3):314-77. PubMed ID: 22433122
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the JAK2-STAT5 pathway in response to acute aerobic exercise.
Consitt LA; Wideman L; Hickey MS; Morrison RF
Med Sci Sports Exerc; 2008 Jun; 40(6):1031-8. PubMed ID: 18461004
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.
Rabkin R; Sun DF; Chen Y; Tan J; Schaefer F
Pediatr Nephrol; 2005 Mar; 20(3):313-8. PubMed ID: 15692835
[TBL] [Abstract][Full Text] [Related]
14. GH-IGF-I axis in non-obese women with functional hyperandrogenism.
Legan M; Kocijancic A; Prezelj J; Osredkar J; Fisker S
J Endocrinol Invest; 2002 Sep; 25(8):691-5. PubMed ID: 12240900
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment.
Fisker S; Kristensen K; Rosenfalck AM; Pedersen SB; Ebdrup L; Richelsen B; Hilsted J; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2001 Feb; 86(2):792-6. PubMed ID: 11158048
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein.
Fisker S; Hansen B; Fuglsang J; Kristensen K; Ovesen P; Ørskov H; Jørgensen JO
Eur J Endocrinol; 2004 Jun; 150(6):773-7. PubMed ID: 15191346
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
[TBL] [Abstract][Full Text] [Related]
19. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
Amit T; Youdim MB; Hochberg Z
J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
